Press Release: Solid Biosciences Provides Fourth Quarter and Full-Year 2022 Business Update and Financial Results
Dow Jones · 03/23/2023 12:00
Share
Please log in to view news
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
Share your ideas here…
All Comments
Related News
Solid Biosciences Is Maintained at Overweight by Barclays
Dow Jones · 2d ago
Solid Biosciences Price Target Cut to $18.00/Share From $21.00 by Barclays
Dow Jones · 2d ago
*Solid Biosciences 1Q Research and Development Expenses $18.9M >SLDB
Dow Jones · 3d ago
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2024 Webull. All Rights Reserved